
Mecuris strives to be the key enabler for digitally manufactured O&P solutions worldwide. They empower O&P professionals to co-create customised O&P products and enrich wearer’s lives within 24 hours.To reach this goal, they team up with O&P professionals to co-create - with users and wearers - customised O&P products. Their digital mindset and 3D printing know-how synergise in the Mecuris Solution Platform, which simplifies the work of O&P professionals and enriches wearers’ lives. The Mecuris Solution Platform uses patient data and scans to semi-automatically individualise 3D designs of patient aids. It makes them ready-to-print at a local 3D printing hub. This enables a 100% customised fit, functionality and look. They thereby cut production times by 75% for the medical practitioners and wearers.

Mecuris strives to be the key enabler for digitally manufactured O&P solutions worldwide. They empower O&P professionals to co-create customised O&P products and enrich wearer’s lives within 24 hours.To reach this goal, they team up with O&P professionals to co-create - with users and wearers - customised O&P products. Their digital mindset and 3D printing know-how synergise in the Mecuris Solution Platform, which simplifies the work of O&P professionals and enriches wearers’ lives. The Mecuris Solution Platform uses patient data and scans to semi-automatically individualise 3D designs of patient aids. It makes them ready-to-print at a local 3D printing hub. This enables a 100% customised fit, functionality and look. They thereby cut production times by 75% for the medical practitioners and wearers.
Headquarters: Munich, Germany
Product: 3D-printed, patient-specific prostheses and orthoses via Mecuris Solution Platform
Founded: May 2016
Total funding: ≈ $8.13M
Last known round: Series B (announced 2020-01-14)
Orthotics & prosthetics (medical devices) — digital manufacturing and customization workflow for patient-specific aids
2016
Medtech
€3.6M
Announced Series B round with investors including Vesalius Biocapital Partners, Sana Kliniken, Mulcan International Investments, HTGF and Bayern Kapital (per funding records).
“Investors include Bayern Kapital, HTGF (High-Tech Gründerfonds), Sana Kliniken, Vesalius Biocapital Partners, Mulcan International Investments”